Form 4: John Patience Reports Bio-De-Six Inc. Stock Transactions

John Patience, Director and Chairman of Bio-De-Six Inc., reported a transaction involving the acquisition of 1,361 restricted stock units.

Summary

• John Patience, a Director and Chairman of Bio-De-Six Inc. (BDSX), reported a transaction on June 30, 2026.
• The transaction involved the acquisition of 1,361 restricted stock units (RSUs).
• Following this transaction, Mr. Patience directly holds 25,383 shares of common stock.
• Additionally, he beneficially owns 107,664 shares through Patience Enterprises LP, 241,480 shares through the John Patience Living Trust, and 2,649 shares through his spouse.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents the acquisition of equity by a key executive, indicating confidence and commitment, but it is a standard reporting event rather than a significant strategic development.

Positives

• Acquisition of 1,361 restricted stock units by a key executive (Director and Chairman).
• The RSUs vest in installments through December 31, 2026, indicating continued service and commitment.
• Significant indirect beneficial ownership through various entities and trusts, suggesting long-term investment.

Risks

• The RSUs are subject to continued service with the Issuer, implying a risk of forfeiture if service is terminated before vesting.
• Indirect beneficial ownership through Patience Enterprises LP carries a disclaimer of beneficial ownership beyond pecuniary interest, which could imply potential complexities or limitations in control.

Future Outlook

The restricted stock units vest in four substantially equal installments on March 31, June 30, September 30, and December 31, 2026, contingent upon the Reporting Person's continued service with the Issuer.

Industry Context

StockSavvy.ai notes that insider transactions, such as the acquisition of restricted stock units by executives and directors, are common in the biotechnology sector as a means of aligning executive interests with shareholder value and incentivizing long-term performance.

Stakeholder Impact

• Shareholders: The acquisition of RSUs by a Director and Chairman can be viewed positively as it aligns executive compensation with company performance and signals continued commitment.
• Employees: The vesting schedule tied to continued service reinforces the importance of employee retention and performance.
• Management: The transaction is a standard part of executive compensation and incentive structures.

Next Steps

• Continued service by John Patience to ensure full vesting of restricted stock units.
• Monitoring of future vesting dates for the RSUs on March 31, June 30, and September 30, 2026.

Key Dates

Keywords

Form 4, SEC Filing, Bio-De-Six Inc., BDSX, John Patience, Restricted Stock Units, RSU, Beneficial Ownership, Insider Transaction, Director, Chairman